Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 02, 2021

SELL
$78.07 - $94.43 $81,583 - $98,679
-1,045 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$82.14 - $91.0 $85,836 - $95,095
1,045 New
1,045 $91,000
Q1 2020

Apr 29, 2020

SELL
$70.67 - $99.01 $68,196 - $95,544
-965 Closed
0 $0
Q3 2019

Oct 22, 2019

BUY
$85.54 - $94.26 $82,546 - $90,960
965 New
965 $84,000
Q2 2019

Jul 26, 2019

SELL
$75.4 - $92.8 $72,761 - $89,552
-965 Closed
0 $0
Q1 2019

Apr 22, 2019

BUY
$75.32 - $86.15 $63,268 - $72,366
840 Added 672.0%
965 $93,000
Q2 2018

Jul 31, 2018

BUY
$64.91 - $73.36 $8,113 - $9,170
125 New
125 $10,000
Q4 2017

Feb 06, 2018

SELL
$72.33 - $77.64 $43,398 - $46,584
-600 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$74.14 - $77.27 $44,484 - $46,362
600
600 $52,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Horan Capital Advisors, Llc. Portfolio

Follow Horan Capital Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Capital Advisors, Llc. with notifications on news.